Recent findings have revealed that flotillin1 and flotillin 2 are frequently overexpressed in various types of human cancers including lung adenocarcinoma, nasopharyngeal carcinoma [47], esophageal squamous cell carcinoma, breast cancer and hepatocellular carcinoma [48]. Here, FLOT2 is linked to breast carcinoma.